Skip to content

Public FDA record

Z-1484-2022: The E-100 Generator (PN 374848-09) is a bipolar electrosurgical unit (ESU) designed to be used with the d

Recall record Z-1484-2022 for Intuitive Surgical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1484-2022
Company in FDA record
Intuitive Surgical, Inc.
FDA record creation date
Aug 1, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to preventative maintenance (PM) not being performed on E-100 generators which is a bipolar electrosugical unit designed to be used with the da Vinci Xi and X systems.

Source facts

Action
On 06/20/2022, the firm sent out an "Medical Device Correction" letter via US direct Mail to customers informing them that the firm became aware that certain testing requirements were not performed during the annual preventative maintenance process for certain E-100 Generators. Specifically, output power calibration, to confirm adherence to specifications for energy delivery to compatible devices, and electrical safety testing, to ensure electrical isolation and ground connection. Customers are instructed that they can continue to use the E-100 Generators and to: 1. Notify all affected hospital personnel about this Medical Device Correction. 2. Complete the attached Acknowledgement Form immediately and return it via fax or email to Intuitive as instructed on the form. 3. Please retain a copy of this letter and the acknowledgement form for their files. 4. Please inform Intuitive of any Adverse Events*/Serious Incidents** or quality problems concerning the use of the subject devices via the standard complaint process. 5. Additionally, if Adverse Events*/Serious Incidents** or quality problems are experienced, please follow your standard reporting process to your health authority, if applicable. 6. Notify affected personnel when the affected product has been replaced by the Intuitive representative. For questions or further assistance: - US, Puerto Rico and Dominican Republic (800) 876-1310, Option 3 (4 AM to 5 PM PST) or mail: customerservice@intusurg.com - Europe, Middle East, Asia, South America and Africa: +800 0821 2020 or +41 21 821 2020 (8 AM to 6 PM CET) or EUCS@intusurg.com - Japan: 0120-56-5635 or 03-5575-1362 (9 AM to 6 PM JST) or csjapan@intusurg.com
Initiated
2022-06-22
Root cause
Process design
Distribution
Worldwide distribution - U.S. Nationwide distribution in the states of AL, AK, AZ, AR, CA, CO, CT, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WV, WI, and WY. The countries of Belgium, Denmark, Germany, Japan, Italy, Monaco, Norway, Sweden, Switzerland, United Kingdom.
Recall number
Z-1484-2022
Recall status
Completed
CDRH record ID
194435
FDA record created
2022-08-01
Recall event number
90452

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗